Postepidemic Analysis of Rift Valley Fever Virus Transmission in Northeastern Kenya
Author Information
Author(s): LaBeaud A. Desirée, Muiruri Samuel, Sutherland Laura J., Dahir Saidi, Gildengorin Ginny, Morrill John, Muchiri Eric M., Peters Clarence J., King Charles H.
Primary Institution: Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute
Hypothesis
We hypothesized that we would be able to identify >13% of individuals in these villages as seropositive for anti-RVFV antibodies.
Conclusion
The study highlights significant variability in RVFV exposure in two neighboring villages and the persistence of anti-RVFV antibodies among previously exposed individuals.
Supporting Evidence
- 44 out of 194 participants were RVFV seropositive, indicating a 23% seroprevalence.
- Consumption of raw milk was strongly associated with RVFV exposure.
- Visual impairment was more likely in the RVFV-seropositive group.
Takeaway
This study looked at how many people in Northeastern Kenya got sick from a virus called Rift Valley fever and found that many people had been exposed, especially those who drank raw milk.
Methodology
A village cohort study was conducted with 194 participants to measure anti-RVFV seroprevalence and identify risk factors for seroconversion.
Potential Biases
The sample may underestimate RVFV exposure as males, who are at higher risk, were less represented.
Limitations
The study had a small sample size and may not fully represent the population due to a higher proportion of women participants.
Participant Demographics
Participants were predominantly Somali or Bantu, with a mix of adults and children, and included both rural and urban residents.
Statistical Information
P-Value
p<0.0001
Confidence Interval
CI95%: 17%–29%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website